NEW YORK (GenomeWeb) – Molecular diagnostics firm Great Basin Scientific reported after the close of the market on Monday that its third quarter revenues rose 33 percent year over year due primarily to growth in its customer base and adoption of its Group B Strep assay.

The company reported revenues of $545,934 for the three months ended Sept. 30, up 33 percent from $409,390 in the third quarter of 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.